Gut microbiome analysis of patients with multiple myeloma receiving idecabtagene vicleucel (ide-cel) therapy revealed specific bacterial species linked to treatment response and toxicity outcomes.
Proteus mirabilis, called A-gyo, and Rhodopseudomonas palustris, called UN-gyo. These two bacteria act like a team. One targets and attacks cancer cells directly, while the other helps control the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback